|
Volumn 42, Issue 9, 2002, Pages 1121-1130
|
Osteoporosis in men: Where do we stand with screening and treatment?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALENDRONIC ACID;
ANDROGEN;
ANTICOAGULANT AGENT;
ANTICONVULSIVE AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CORTICOSTEROID;
PREDNISONE;
RISEDRONIC ACID;
THYROXINE;
ADULT;
AGED;
ARTICLE;
BODY WEIGHT;
BONE DENSITY;
CIGARETTE SMOKING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DRUG INDUCED DISEASE;
DUAL ENERGY X RAY ABSORPTIOMETRY;
FAMILY HISTORY;
HIP FRACTURE;
HUMAN;
LUMBAR SPINE;
MALE;
OSTEOPOROSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SCREENING TEST;
TREATMENT INDICATION;
VERTEBRA FRACTURE;
|
EID: 0036678705
PISSN: 00107069
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (31)
|